Answer
Oct 08, 2026 - 10:00 AM
The active ingredient is zanubrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor that blocks a specific protein involved in the growth and survival of cancer cells. BTK inhibitors like zanubrutinib help slow or stop the progression of B-cell malignancies, which is a significant benefit for patients with these cancers.
